Phillips Katherine G, Stewart Darren, Wayda Brian, Drozdowicz Kelly, Trager Lena, Reyentovich Alex, Leacche Marzia, Alam Amit, Moazami Nader
Department of Cardiothoracic Surgery, NYU Langone Health, New York, NY.
Center for Surgical and Transplant Applied Research, NYU Langone Health, New York, NY.
J Heart Lung Transplant. 2025 Jun 4. doi: 10.1016/j.healun.2025.05.019.
Heart utilization from donation after circulatory death (DCD) donors remains highly variable across the United States, potentially resulting in missed transplantation opportunities. This study aimed to quantify the frequency of clinically viable, non-utilized DCD hearts and identify usage barriers.
We conducted a retrospective, national registry analysis of donors ≤55 years old who donated ≥1 organ, focusing primarily on DCDs. Donor characteristics, particularly age, warm ischemic time (WIT), and ejection fraction (EF), as well as reasons for non-recovery and offer refusal, were analyzed. Scientific Registry of Transplant Recipients (SRTRs) heart yield model was employed to identify non-utilized DCD hearts clinically comparable to transplanted DCD hearts.
In 2023, 613 DCD hearts were transplanted, accounting for 13.5% of all heart transplants. Only 15.5% of DCD hearts from donors ≤55 years old were utilized. Marked variation in risk-adjusted DCD heart yield was observed between states, Organ Procurement Organizations (OPOs), and Regions. Donors of transplanted DCD hearts had a median age of 32, WIT 24 mins, and EF 63%. The yield model identified between 701 and 1,243 non-utilized DCD hearts with characteristics comparable to transplanted cases. Concerns about delayed progression to circulatory arrest after life support withdrawal was a key reason for non-utilization.
Despite wider acceptance of DCD heart transplantation, an increasing proportion of DCD hearts remain unused despite favorable characteristics. Concerns related to delayed progression to circulatory arrest are a significant barrier to heart utilization. Addressing geographic variability and improving predictive models for donor viability could double DCD heart utilization and expand heart transplantation volume by approximately 700-1,200 (15%-27%) annually.
在美国,循环死亡后器官捐献(DCD)供体心脏的利用率差异很大,这可能导致错失移植机会。本研究旨在量化临床上可利用但未被使用的DCD心脏的频率,并确定使用障碍。
我们对年龄≤55岁且捐献≥1个器官的供体进行了一项回顾性全国登记分析,主要关注DCD供体。分析了供体特征,特别是年龄、热缺血时间(WIT)和射血分数(EF),以及未获取和拒绝供心的原因。采用移植受者科学登记处(SRTR)心脏产出模型来识别临床上与已移植DCD心脏相当的未使用DCD心脏。
2023年,613例DCD心脏被移植,占所有心脏移植的13.5%。年龄≤55岁的DCD供体心脏中只有15.5%被利用。在各州、器官获取组织(OPO)和地区之间,观察到风险调整后的DCD心脏产出存在显著差异。已移植DCD心脏的供体中位年龄为32岁,WIT为24分钟,EF为63%。产出模型识别出701至1243例具有与移植病例相当特征的未使用DCD心脏。对生命支持撤除后循环停止延迟进展的担忧是未使用的关键原因。
尽管DCD心脏移植得到了更广泛的接受,但越来越多具有良好特征的DCD心脏仍未被使用。与循环停止延迟进展相关的担忧是心脏利用的重大障碍。解决地理差异并改进供体生存能力的预测模型可能会使DCD心脏利用率提高一倍,并使心脏移植量每年增加约700 - 1200例(15% - 27%)。